306 related articles for article (PubMed ID: 28689666)
21. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
23. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
[TBL] [Abstract][Full Text] [Related]
24. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
25. Diethylstilbestrol in pregnancy: an update.
Kinch RA
Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
[TBL] [Abstract][Full Text] [Related]
26. DES exposure: an update.
Mittendorf R; Herbst AL
Contemp Pediatr; 1994 Nov; 11(11):59-62, 64, 66 passim. PubMed ID: 10150281
[TBL] [Abstract][Full Text] [Related]
27. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
28. Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring.
Conlon JL
JAAPA; 2017 Feb; 30(2):49-52. PubMed ID: 28098674
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological studies of the effects of diethylstilboestrol.
Vessey MP
IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Norusis MJ; Welch WR; Scully RE
Am J Obstet Gynecol; 1979 Dec; 135(7):876-86. PubMed ID: 507130
[TBL] [Abstract][Full Text] [Related]
31. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
[TBL] [Abstract][Full Text] [Related]
32. [DES Daughter--expertise remains necessary].
Verheijen RH; Verloop J; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2013; 157(52):A6809. PubMed ID: 24382040
[TBL] [Abstract][Full Text] [Related]
33. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
34. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
Blythe JG; Michael H; Hodel KA
J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
[TBL] [Abstract][Full Text] [Related]
35. Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol.
Bornstein J; Adam E; Adler-Storthz K; Kaufman RH
Obstet Gynecol Surv; 1988 Jan; 43(1):15-21. PubMed ID: 2829071
[TBL] [Abstract][Full Text] [Related]
36. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
Treffers PE; Hanselaar AG; Helmerhorst TJ; Koster ME; van Leeuwen FE
Ned Tijdschr Geneeskd; 2001 Apr; 145(14):675-80. PubMed ID: 11530703
[TBL] [Abstract][Full Text] [Related]
37. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
[TBL] [Abstract][Full Text] [Related]
38. Screening for cancers of the cervix and vagina for women exposed to diethylstilbestrol (DES) in utero.
Tournaire M; Devouche E; Lafaye N; Levadou A
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102042. PubMed ID: 33310134
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma.
Palmer JR; Anderson D; Helmrich SP; Herbst AL
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):814-20. PubMed ID: 10831973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
